Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

416 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Trans men can achieve adequate muscular development through low-dose testosterone therapy: A long-term study on body composition changes.
Tominaga Y, Kobayashi T, Matsumoto Y, Moriwake T, Oshima Y, Okumura M, Horii S, Sadahira T, Katayama S, Iwata T, Nishimura S, Bekku K, Edamura K, Sugimoto M, Kobayashi Y, Watanabe M, Namba Y, Matsumoto Y, Nakatsuka M, Araki M. Tominaga Y, et al. Among authors: namba y. Andrology. 2024 Apr 2. doi: 10.1111/andr.13640. Online ahead of print. Andrology. 2024. PMID: 38563871
Protocol to evaluate the efficacy and safety of tolvaptan in patients with refractory ascites after liver resection: an open-label, single-arm phase I/II study.
Namba Y, Kobayashi T, Kuroda S, Hashimoto M, Takei D, Fukuhara S, Oshita K, Matsubara K, Honmyo N, Nakano R, Sakai H, Tahara H, Ohira M, Ide K, Ohdan H. Namba Y, et al. Int J Surg Protoc. 2023 Dec 15;28(1):1-5. doi: 10.1097/SP9.0000000000000015. eCollection 2024 Mar. Int J Surg Protoc. 2023. PMID: 38433869 Free PMC article.
Effectiveness and Safety of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in Pulmonary Sarcomatoid Carcinoma.
Hazama D, Nakahama K, Kodama H, Miyazaki A, Azuma K, Kawashima Y, Sato Y, Ito K, Shiraishi Y, Miura K, Takahama T, Oizumi S, Namba Y, Ikeda S, Yoshioka H, Tsuya A, Yasuda Y, Negi Y, Hara A, Toda M, Tachihara M. Hazama D, et al. Among authors: namba y. JTO Clin Res Rep. 2023 Nov 27;5(1):100613. doi: 10.1016/j.jtocrr.2023.100613. eCollection 2024 Jan. JTO Clin Res Rep. 2023. PMID: 38229769 Free PMC article.
Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell lung cancer: a multicenter retrospective comparative study.
Matsumoto K, Shiroyama T, Tamiya M, Minami T, Kinehara Y, Tamiya A, Suga Y, Kuge T, Mori M, Suzuki H, Tobita S, Ueno K, Namba Y, Tetsumoto S, Niki T, Morimura O, Osa A, Nishino K, Nagatomo I, Takeda Y, Kijima T, Kumanogoh A. Matsumoto K, et al. Among authors: namba y. Cancer Immunol Immunother. 2024 Jan 4;73(1):4. doi: 10.1007/s00262-023-03583-4. Cancer Immunol Immunother. 2024. PMID: 38175294 Free PMC article.
Preoperative percutaneous or transvascular marking for curative resection of small liver tumours with potential for missing during hepatectomy: a study protocol for an open-label, single-arm phase II study.
Fukuhara S, Kuroda S, Kobayashi T, Takei D, Namba Y, Oshita K, Matsubara K, Honmyo N, Nakano R, Sakai H, Tahara H, Ohira M, Kawaoka T, Tsuge M, Chosa K, Awai K, Ohdan H. Fukuhara S, et al. Among authors: namba y. BMJ Open. 2023 Oct 27;13(10):e075891. doi: 10.1136/bmjopen-2023-075891. BMJ Open. 2023. PMID: 37890974 Free PMC article.
416 results